Recap: OptimizeRx Q2 Earnings

Comments
Loading...

 

OptimizeRx OPRX reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

OptimizeRx missed estimated earnings by 55.56%, reporting an EPS of $0.04 versus an estimate of $0.09.

Revenue was up $353 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 6.54% drop in the share price the next day.

Here's a look at OptimizeRx's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.01 0.20 0.13 0.07
EPS Actual -0.01 0.22 0.09 0.10
Revenue Estimate 13.97M 20.16M 15.06M 12.45M
Revenue Actual 13.73M 20.31M 16.12M 13.63M

To track all earnings releases for OptimizeRx visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!